Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000126631 | SCV000170138 | benign | not specified | 2013-01-31 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV000126631 | SCV000308821 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000325082 | SCV000382236 | benign | DNA ligase IV deficiency | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV000382071 | SCV000382237 | benign | Severe combined immunodeficiency due to DCLRE1C deficiency | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Laboratory for Molecular Medicine, |
RCV000126631 | SCV000539534 | benign | not specified | 2016-03-29 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency, Clinvar assertions are benign and protective (not pathogenic) |
Labcorp Genetics |
RCV000325082 | SCV001000324 | benign | DNA ligase IV deficiency | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000126631 | SCV002051451 | likely benign | not specified | 2021-12-03 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV000325082 | SCV004015809 | benign | DNA ligase IV deficiency | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV000126631 | SCV004102287 | benign | not specified | 2023-11-12 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 39% of patients studied by a panel of primary immunodeficiencies. Number of patients: 37. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV001705586 | SCV005218253 | likely benign | not provided | criteria provided, single submitter | not provided | ||
OMIM | RCV000008116 | SCV000028321 | protective | Multiple myeloma, resistance to | 2015-05-18 | no assertion criteria provided | literature only | |
Diagnostic Laboratory, |
RCV000126631 | SCV001742504 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001705586 | SCV001930880 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome |
RCV001705586 | SCV002074688 | not provided | not provided | no assertion provided | phenotyping only | Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. |